Article info
PDFClinical and epidemiological research
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients
- Correspondence to Professor Daniel Aletaha, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria; daniel.aletaha{at}meduniwien.ac.at
Citation
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients
Publication history
- Received May 7, 2012
- Accepted July 20, 2012
- First published August 21, 2012.
Online issue publication
December 12, 2012
Article Versions
- Previous version (21 August 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions